PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Vanda Pharmaceuticals Inc., 2200 Pennsylvania NW, Suite 300-E, Washington, DC 20037, USA. Electronic address: sandra.smieszek@vandapharma.com.\', \'Vanda Pharmaceuticals Inc., 2200 Pennsylvania NW, Suite 300-E, Washington, DC 20037, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S2213-7165(21)00156-910.1016/j.jgar.2021.06.005
?:hasPublicationType
?:journal
  • Journal of global antimicrobial resistance
is ?:pmid of
?:pmid
?:pmid
  • 34273592
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.658
?:rankingScore_hIndex
  • 13
is ?:relation_isRelatedTo_publication of
?:title
  • Loss-of-function mutations in IFNAR2 in COVID-19 severe infection susceptibility.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34273592>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34273592>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all